Hypera S.A. (OTCMKTS:HYPMY - Get Free Report)'s stock price passed above its fifty day moving average during trading on Thursday . The stock has a fifty day moving average of $3.34 and traded as high as $3.59. Hypera shares last traded at $3.59, with a volume of 308 shares trading hands.
Hypera Trading Down 6.7 %
The company has a current ratio of 1.81, a quick ratio of 1.41 and a debt-to-equity ratio of 0.68. The stock has a market cap of $2.02 billion, a price-to-earnings ratio of 7.98 and a beta of 0.75. The company has a fifty day simple moving average of $3.36 and a 200-day simple moving average of $3.58.
Hypera (OTCMKTS:HYPMY - Get Free Report) last issued its quarterly earnings results on Thursday, March 20th. The company reported $0.02 EPS for the quarter. Hypera had a net margin of 20.04% and a return on equity of 13.18%. The business had revenue of $258.56 million during the quarter.
About Hypera
(
Get Free Report)
Hypera SA operates as a pharmaceutical company in Brazil. It offers prescription products under the Adacne, Addera, apri, AmpliumG, please, Celestamine, Celestone, Celestone Soluspan, Cizax, deciprax, Derive C Micro, Micro Drift, Dermotil Fusid, Digedrat, diprogent, Diprosalic, Diprosone, diprospan, Emprol XR, Flow, Garasone, Halobex, Lipanon, moon, Lydian, macrodantin, Max Sulid, milgamma, Mioflex A, nesina, Novotram, oximax, peridal, Peridal Suspension, PredSim, Pressaliv, Quadriderm, Rizi, Rizi M, softalm, tacroz, tinodin, umma, and velunid brands.
Recommended Stories
Before you consider Hypera, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Hypera wasn't on the list.
While Hypera currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
